University of Wollongong
Browse

Safe use of sodium valproate

Download (313.26 kB)
journal contribution
posted on 2024-11-16, 01:34 authored by Ahamed Zawab, John Carmody
Valproate is an anticonvulsant drug which is approved for use in epilepsy and bipolar disorder. It has also been used for neuropathic pain and migraine prophylaxis. Gastrointestinal adverse effects are common, particularly at the start of therapy. Important adverse effects include pancreatitis, hepatitis, weight gain and sedation. There is an increased risk of fetal abnormalities if valproate is taken in pregnancy. Measuring concentrations of serum valproate is often unnecessary. They do not correlate closely with its therapeutic effects. If withdrawal of valproate is required, this should be done slowly if possible. Rapid cessation may provoke seizures in patients with epilepsy.

History

Citation

Zawab, A. & Carmody, J. (2014). Safe use of sodium valproate. Australian Prescriber, 37 (4), 124-127. © Copyright 2014. Australian Prescriber - reproduce with permission.

Journal title

Australian Prescriber

Volume

37

Issue

4

Pagination

124-127

Language

English

Notes

Paper reproduced with permission from Australian Prescriber

RIS ID

92705

Usage metrics

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC